Vivra Inc. completes public offering.
Of the 1,800,000 shares offered, 1,725,000 were sold by Vivra and 75,000 were sold by the selling stockholder. Vivra has granted the underwriters an option to purchase an additional 270,000 shares to cover over-allotments, if any. Vivra's common stock is listed on the New York Stock Exchange under the symbol "V."
Vivra is a provider of specialty health care services, principally the delivery of dialysis services. It also provides diabetes management, specialized pharmacy, asthma allergy care, rehabilitation therapy, ambulatory surgery and physician practice management services. Vivra is the second largest provider of dialysis care in the United States.
A prospectus relating to these securities may be obtained from Alex. Brown & Sons Inc., 135 East Baltimore St., Baltimore, MD 21202, Attn: Prospectus Department, Dean Witter Reynolds Inc., 2 World Trade Center, New York, NY 10048, Attn: Prospectus Department and Montgomery Securities, 600 Montgomery St., San Francisco, CA 94111, Attn: Prospectus Department.
CONTACT: Vivra Inc.
Kent J. Thiry, 415/375-7500
LeAnne M. Zumwalt, 714/831-0900, ext. 346
William H. Malkmus, 415/375-7506
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 10, 1995|
|Previous Article:||Sierra On-Line announces new vice president of marketing.|
|Next Article:||Celebrity Inc. expands product offerings with acquisition of India exotics; unaffected by threatened China trade sanctions.|